Bruker Corporation Reports Record Financial Results for the Fourth Quarter and Full Year 2009

Bruker Corporation Reports Record Financial Results

for the Fourth Quarter and Full Year 2009

BILLERICA, Mass., February 25, 2010 (BUSINESS WIRE)

Bruker Corporation (NASDAQ: BRKR) today reported financial results for

the fourth quarter and year ended December 31, 2009.

In the fourth quarter of 2009, GAAP revenue increased by 16% to $366.4

million, compared to revenue of $315.2 million in the fourth quarter of

2008. Excluding the effects of foreign

currency translation, fourth quarter revenue increased by 6%

year-over-year. In the fourth quarter of

2009, GAAP revenue increased by 13% year-over-year for the Bruker Scientific

Instruments (BSI) segment, and by 116% year-over-year for the Bruker Energy &

Supercon Technologies (BEST) segment.

GAAP operating income in the fourth quarter of 2009 was $76.2 million,

compared to $48.9 million in the fourth quarter of 2008. GAAP net income for the fourth quarter of

2009 was $43.5 million, or $0.26 per diluted share, compared to $26.2 million,

or $0.16 per diluted share, in the fourth quarter of 2008. Included in GAAP EPS for the fourth quarter

2009 was non-cash stock-based compensation expense of ($0.01) per diluted

share, the same as in the fourth quarter of 2008.

the year 2009, GAAP revenue increased by 1% to $1,114.5 million, compared to

revenue of $1,107.1 million for the year 2008.

Excluding the effects of foreign currency translation, full year 2009

revenue increased by 2% year-over-year.

For the year 2009, GAAP revenue decreased 1% to $1,062.7 million for the

BSI segment, and increased 37% to $59.8 million for the BEST segment, compared

the year 2009, GAAP operating income was $136.7 million, compared to $108.2

million for the year 2008. Operating

income for the BSI segment in 2009 was $141.7 million, compared to $116.2

million in 2008. In the year 2009, BSI operating income was favorably

impacted by $6.7 million, or by 60 basis points, upon recognizing revenue for

the world s first 1 GHz NMR system, for which the majority of R&D expenses

the year 2009, GAAP net income was $81.2 million, or $0.49 per diluted share,

compared to $64.9 million, or $0.39 per diluted share, in 2008. Included in GAAP EPS for the full year 2009

was non-cash stock-based compensation expense of ($0.03) per diluted share,

compared to ($0.02) per diluted share for 2008.

For the year 2009, the BSI segment contributed GAAP earnings of $0.53

per diluted share, compared to $0.44 in 2008.

For the year 2009, the BEST segment contributed a GAAP loss of ($0.04)

per diluted share, compared to ($0.05) in 2008.

Cash flow from operations for the full year 2009 was $149.8 million,

compared to $106.9 million in 2008. Free

cash flow, defined as operating cash flow less capital expenditures, was $131.7

million during 2009, compared to $59.5 million during 2008. During the year 2009, the Company repaid

$86.1 million of debt, and as of December 31, 2009, Bruker had cash, cash

equivalents and restricted cash of $209.1 million and net cash of $71.4

Frank Laukien, President and CEO, commented: Given the challenging

economic conditions in 2009, we are extremely pleased that we could exceed our

full-year 2009 financial goals with year-over-year

currency-adjusted total

revenue growth of 2%,

BSI improvement in GAAP

operating margin of 250 basis points,

BSI increase in GAAP net

plus excellent improvements in cash flow.

This success is directly attributable to the strength of our

high-performance, innovative scientific instruments and analytical solutions

portfolio, as well as to the enthusiasm and customer focus of our global Bruker

Moreover, we are also pleased with the recent acceleration in growth of

BEST, which more than doubled its fourth quarter 2009 revenue

year-over-year. We are optimistic about

the prospects for this intrapreneurial venture, as BEST further develops its

broad technology base in superconducting materials and devices, in order to

address potentially large emerging markets in clean tech, alternative energy

and big science infrastructure.

Dr. Laukien continued: In 2010, as

Bruker celebrates its 50th anniversary, our goal is to build on our

success over the past 50 years by remaining true to our innovation and

profitable growth strategy. We believe

that our commitment to R&D and customer focus, coupled with emphasis on

operational excellence, can generate further improvements in financial

performance. Our financial goals for the

total Bruker currency-adjusted revenue growth

BSI operating margin improvement of greater

than 125 basis points, excluding the 60 basis point favorable impact from the 1

GHz NMR recognized in 2009,

BSI net income and EPS increase of greater

BSI working capital decrease of more than 5%.

For our BEST segment, in 2010 we plan greater

than 25% revenue growth, continued infrastructure, marketing and R&D

investments for clean-tech and alternative energy applications, with an

expected BEST 2010 operating loss of $7-8 million.

EARNINGS CONFERENCE CALL

Bruker Corporation will host an

operator-assisted earnings conference call at 9:00 a.m. Eastern Time on

Thursday, February 25, 2010. To

listen to the webcast, investors can go to http://ir.bruker.com and click on

the live web broadcast symbol. The

webcast will be available through the Company web site for 30 days. Investors can also listen and participate on

the telephone in the US and Canada by calling 800-688-0796, or +1-617-614-4070

outside the US and Canada. Investors

should refer to the Bruker Earnings Call.

A telephone replay of the conference call will be available one hour

after the conference call by dialing 888-286-8010 in the US and Canada, or

+1-617-801-6888 outside the US and Canada, and then entering replay pass code

24438469. For more information, please visit http://ir.bruker.com

CAUTIONARY STATEMENT

Any statements contained in this presentation that do not describe

historical facts may constitute forward-looking statements as that term is